These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38881603)

  • 1. Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration.
    Pierce EA; Ashimatey BS; Jayasundera T; Hoyng C; Lam BL; Lorenz B; Kim K; Rashid A; Myers R; Pennesi ME
    Ophthalmol Sci; 2024; 4(5):100483. PubMed ID: 38881603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting.
    Lorenz B; Künzel SH; Preising MN; Scholz JP; Chang P; Holz FG; Herrmann P
    Ophthalmology; 2024 Feb; 131(2):161-178. PubMed ID: 37704110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Editing for
    Pierce EA; Aleman TS; Jayasundera KT; Ashimatey BS; Kim K; Rashid A; Jaskolka MC; Myers RL; Lam BL; Bailey ST; Comander JI; Lauer AK; Maguire AM; Pennesi ME
    N Engl J Med; 2024 Jun; 390(21):1972-1984. PubMed ID: 38709228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RP2-Associated X-linked Retinopathy: Clinical Findings, Molecular Genetics, and Natural History.
    Georgiou M; Robson AG; Jovanovic K; Guimarães TAC; Ali N; Pontikos N; Uwaydat SH; Mahroo OA; Cheetham ME; Webster AR; Hardcastle AJ; Michaelides M
    Ophthalmology; 2023 Apr; 130(4):413-422. PubMed ID: 36423731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Phenotypic Spectrum of Ophthalmic Changes in CEP290 Mutations].
    Preising MN; Schneider U; Friedburg C; Gruber H; Lindner S; Lorenz B
    Klin Monbl Augenheilkd; 2019 Mar; 236(3):244-252. PubMed ID: 30897646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Full-field stimulus threshold testing for evaluation of the retinal function in patients with inherited retinal dystrophy].
    Li H; Zou X; Han XX; Sui RF
    Zhonghua Yan Ke Za Zhi; 2022 Dec; 58(12):1039-1044. PubMed ID: 36480885
    [No Abstract]   [Full Text] [Related]  

  • 7. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.
    Carpineto P; Ciancaglini M; Di Antonio L; Gavalas C; Mastropasqua L
    Retina; 2007 Jan; 27(1):21-9. PubMed ID: 17218911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization of 66 Patients With Congenital Retinal Disease Due to the Deep-Intronic c.2991+1655A>G Mutation in CEP290.
    Valkenburg D; van Cauwenbergh C; Lorenz B; van Genderen MM; Bertelsen M; Pott JR; Coppieters F; de Zaeytijd J; Thiadens AAHJ; Klaver CCW; Kroes HY; van Schooneveld MJ; Preising M; Hoyng CB; Leroy BP; van den Born LI; Collin RWJ
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4384-4391. PubMed ID: 30193310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prosthetic Visual Acuity with the PRIMA Subretinal Microchip in Patients with Atrophic Age-Related Macular Degeneration at 4 Years Follow-up.
    Muqit MMK; Le Mer Y; Olmos de Koo L; Holz FG; Sahel JA; Palanker D
    Ophthalmol Sci; 2024; 4(5):100510. PubMed ID: 38881600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice.
    Melillo P; Testa F; Di Iorio V; Karali M; Citro A; Della Corte M; Rossi S; Banfi S; Simonelli F
    Ophthalmol Retina; 2024 Jul; 8(7):688-698. PubMed ID: 38295874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Disease Severity in Nonsyndromic Patients With Mutations in the CEP290 Gene: A Multicentric Longitudinal Study.
    Testa F; Sodi A; Signorini S; Di Iorio V; Murro V; Brunetti-Pierri R; Valente EM; Karali M; Melillo P; Banfi S; Simonelli F
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):1. PubMed ID: 34196655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.
    Allingham MJ; Mettu PS; Cousins SW
    Ophthalmol Sci; 2022 Mar; 2(1):100095. PubMed ID: 36246187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual improvement after cultivated oral mucosal epithelial transplantation.
    Sotozono C; Inatomi T; Nakamura T; Koizumi N; Yokoi N; Ueta M; Matsuyama K; Miyakoda K; Kaneda H; Fukushima M; Kinoshita S
    Ophthalmology; 2013 Jan; 120(1):193-200. PubMed ID: 23084239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT Predictors of 3-Year Visual Outcome for Type 3 Macular Neovascularization.
    Sacconi R; Forte P; Tombolini B; Grosso D; Fantaguzzi F; Pina A; Querques L; Bandello F; Querques G
    Ophthalmol Retina; 2022 Jul; 6(7):586-594. PubMed ID: 35227948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1/2 Sepofarsen Trial.
    Cideciyan AV; Jacobson SG; Ho AC; Krishnan AK; Roman AJ; Garafalo AV; Wu V; Swider M; Sumaroka A; Van Cauwenbergh C; Russell SR; Drack AV; Leroy BP; Schwartz MR; Girach A
    Ophthalmol Sci; 2022 Jun; 2(2):100133. PubMed ID: 36249682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion.
    Nagasato D; Muraoka Y; Tanabe M; Nishigori N; Osaka R; Mitamura Y; Tabuchi H; Murakami T; Ooto S; Suzuma K; Tsujikawa A
    Ophthalmol Sci; 2024; 4(2):100418. PubMed ID: 38146527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review.
    Yergeau C; Coussa RG; Antaki F; Argyriou C; Koenekoop RK; Braverman NE
    Ophthalmology; 2023 Dec; 130(12):1313-1326. PubMed ID: 37541626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.